KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aurinia Pharmaceuticals (AUPH) Non-cash Items (2018 - 2020)

Historic Non-cash Items for Aurinia Pharmaceuticals (AUPH) over the last 5 years, with Q3 2020 value amounting to -$37.0 million.

  • Aurinia Pharmaceuticals' Non-cash Items fell 27581.52% to -$37.0 million in Q3 2020 from the same period last year, while for Sep 2020 it was -$193.0 million, marking a year-over-year decrease of 51397.08%. This contributed to the annual value of -$65.5 million for FY2019, which is 4357.6% down from last year.
  • According to the latest figures from Q3 2020, Aurinia Pharmaceuticals' Non-cash Items is -$37.0 million, which was down 27581.52% from -$21.9 million recorded in Q2 2020.
  • Over the past 5 years, Aurinia Pharmaceuticals' Non-cash Items peaked at $21.0 million during Q3 2019, and registered a low of -$112.8 million during Q4 2019.
  • Its 3-year average for Non-cash Items is -$17.4 million, with a median of $10.3 million in 2018.
  • As far as peak fluctuations go, Aurinia Pharmaceuticals' Non-cash Items soared by 8184.8% in 2019, and later tumbled by 27581.52% in 2020.
  • Quarter analysis of 3 years shows Aurinia Pharmaceuticals' Non-cash Items stood at -$78.8 million in 2018, then crashed by 43.23% to -$112.8 million in 2019, then soared by 67.21% to -$37.0 million in 2020.
  • Its Non-cash Items was -$37.0 million in Q3 2020, compared to -$21.9 million in Q2 2020 and -$21.3 million in Q1 2020.